NEW YORK, March 22, 2019 — The National Law Journal has named King & Spalding partner Gerald Flattmann to its 2019 list of Intellectual Property Trailblazers.
In a profile of Flattmann, the publication highlighted his successes as the firm’s global chair of the Life Sciences Patent Litigation practice. Flattmann originally intended to become a neurosurgeon, but realized after doing both medical and law internships that the legal industry suited him best. He told the publication: “I realized patent law was a way to marry my love of science and the law.”
The NLJ’s Trailblazers list recognizes lawyers, chosen from hundreds of nominations, who “have shown a deep passion and perseverance in pursuit of their mission, having achieved remarkable successes along the way,” according to the publication.
Flattmann, who is based in New York City, focuses his practice on intellectual property matters, including pharmaceutical and biotechnology patent litigation. He has over 25 years’ experience representing companies at the forefront of these technologies. He litigates high-stakes patent disputes in federal district courts and before the Patent Trial and Appeal Board of the U.S. Patent Office.
About King & Spalding
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with more than 1,100 lawyers in 20 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.